Animal health company Ceva is reshaping its capital structure through a new round of financing that strengthens its position as a majority shareholder, while welcoming a new investor to support the group in a new phase of development. The reshaped capital structure will support Ceva’s ambition to become the first independent player within the top 5 global animal health companies by 2020, the company stated.
Temasek, an investment company based in Singapore, will become a new Ceva investor, and will be joined by Ceva’s French and international financial investors. French partners Euromezzanine and Sagard, which are historical partners of the group, will reinvest significantly in Ceva, as well as CDH Investments, the pioneering China-based fund.
“I’m delighted that we have been able to bring together this diversified consortium of strong and committed investors,” said Marc Prikaszsky, Ceva CEO. “As we are making progress through the implementation of our 2020 ambition plan, it was essential to select partners who share our vision and can actively contribute to its achievement. We are grateful for the confidence that our financial partners – new and old – have placed in us and I know that the committed and talented team we have at Ceva will ensure that we achieve success – together.”